Jacobs Levy Equity Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$351K Buy
+58,657
New +$441K ﹤0.01% 869
2024
Q4
Sell
-1,242,135
Closed -$23.8M 1016
2024
Q3
$23.8M Buy
1,242,135
+934,505
+304% +$19.4M 0.09% 210
2024
Q2
$6.37M Buy
307,630
+2,282
+0.7% +$45.4K 0.03% 408
2024
Q1
$5.74M Sell
305,348
-597,679
-66% -$10.3M 0.03% 399
2023
Q4
$13M Sell
903,027
-51,525
-5% -$701K 0.07% 266
2023
Q3
$16.6M Sell
954,552
-103,744
-10% -$2.16M 0.1% 203
2023
Q2
$22M Buy
1,058,296
+343,325
+48% +$7.46M 0.13% 184
2023
Q1
$16.8M Buy
714,971
+510,242
+249% +$13.7M 0.1% 217
2022
Q4
$5.72M Sell
204,729
-172,433
-46% -$4.41M 0.04% 367
2022
Q3
$8.83M Buy
377,162
+141,062
+60% +$4.26M 0.07% 277
2022
Q2
$7.97M Buy
236,100
+85,949
+57% +$3.01M 0.06% 325
2022
Q1
$5.25M Buy
+150,151
New +$5.13M 0.04% 409
2021
Q4
Sell
-36,299
Closed -$1.19M 1047
2021
Q3
$1.19M Buy
+36,299
New +$1.16M 0.01% 721

Other funds holding OGN

Jacobs Levy Equity Management's OGN Position: Q1 2026 in Review

Jacobs Levy Equity Management opened a new position in Organon & Co (OGN) in Q1 2026: 58,657 shares worth $351K. The stake represents ﹤0.01% of the portfolio and ranks #869 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in OGN as recently as Q3 2024.

Jacobs Levy Equity Management first reported a position in OGN in Q3 2021 and has held it in 13 quarters since. The position peaked at $23.8M in Q3 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Jacobs Levy Equity Management held 58,657 shares of Organon & Co worth $351K as of Q1 2026.
  • Organon & Co was a new Jacobs Levy Equity Management position in Q1 2026.
  • Organon & Co made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #869 holding.
  • Jacobs Levy Equity Management first reported a position in Organon & Co in Q3 2021 and has held it in 13 quarters since.
  • Jacobs Levy Equity Management's Organon & Co position peaked at $23.8M in Q3 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.